Registered entities
Exicure, Inc.
Reg. No. 1698530United States
Exicure, Inc.
Reg. No. 81-5333008United States
AuraSense Therapeutics, LLC
Reg. No. 1539169United States
Innovation
22 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 3,886 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 9 |
| 2017 | 11 |
| 2018 | 7 |
| 2019 | 12 |
| 2020 | 13 |
| 2021 | 5 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Social engagement
Social engagement: 4.1K social following, 2 posts in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include Abbott Biotech Ventures, Luye Pharma.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 35% |
| Bank & private debt | 1 | 5% |
| Other / undisclosed | 12 | 60% |
Recent activity
21 Jan 2026
Event
Tandem Meetings